Tenmile
Perth, Western Australiatenmile.com
Overview
Tenmile is a dedicated health technology investment business owned by Tattarang, one of Australia's largest private investment groups. With an initial capital allocation of $250 million, they invest in products and solutions addressing unmet medical needs that support sustainable and equitable healthcare. They focus on providing seed and expansion capital to HealthTech companies with innovative solutions to healthcare needs that fill a gap in existing markets and services.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| AdvanCell | Jul 2026 | Series D | Co-investor |
| Antares Therapeutics | Jun 2025 | Series A | Co-investor |
| Gate Neurosciences | May 2025 | M&A | Co-investor |
| Syndeio Biosciences | May 2025 | VC Round | Co-investor |
| AdvanCell | Feb 2025 | Series C | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
